Food and Drug Administration Foreign Drug Inspection Program
Government Accountability Office (GAO) Health Care Director Mary Denigan-Macauley testified on the Food and Drug Administration’s foreign dr… read more
Government Accountability Office (GAO) Health Care Director Mary Denigan-Macauley testified on the Food and Drug Administration’s foreign drug inspection program. She outlined the challenges of the program, including staffing vacancies and the inspections backlog due to the coronavirus pandemic. Ms. Denigan-Macauley acknowledged the agency had made some progress by increasing its overseas drug inspections. Lawmakers also questioned the witness about FDA resources, drug safety issues, and FDA inspections in China and India. close
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and tap the screen to see the at the bottom of the player. Tap the to see a complete list of all Points of Interest - click on any moment in the list and the video will play.
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and move your cursor over the video to see the . Click on the marker to see the description and watch.
You can also click the in the lower left of the video player to see a complete list of all Points of Interest from this program - click on any moment in the list and the video will play.
People in this video
More PeopleHosting Organization
Related Video
-
COVID-19 Pandemic and Federal Prisons
The Federal Bureau of Prisons Director Michael Carvajal testified before the House Appropriations Subcommittee on Commer…
-
IRS Oversight During COVID-19 Pandemic
Internal Revenue Service (IRS) Commissioner Charles Rettig testified before the Financial Services and General Governmen…
-
House Hearing on Child Care During COVID-19 Pandemic
A House appropriations subcommittee held a hearing on child care during the coronavirus pandemic. Child care analysts, a…
-
FDA Commissioner Dr. Stephen Hahn on Coronavirus Response
Food and Drug Administration (FDA) Commissioner Dr. Stephen Hahn discussed the FDA’s role in responding to the coronavir…